The phrase "a potent cell" is correct and usable in written English.
It can be used in contexts discussing biology, medicine, or any field where the strength or effectiveness of a cell is relevant.
Example: "The researchers discovered a potent cell that could significantly enhance the immune response to infections."
Alternatives: "a powerful cell" or "an effective cell".
Through these efforts compound 2 was identified as a potent (cell IC50 = 15 nM) BACE inhibitor with acceptable ADME properties.
Nitric oxide, in particular, is a potent cell signaling molecule that participates in diverse biological pathways and events.
These data demonstrate that therapy with NSCs-mTRAIL is a potent cell based approach for treatment of glioma.
MSCs were isolated from four osteoarthritic (OA) patients, along with meniscal fibrochondrocytes (FC) which have proven to be a potent cell source for engineering fibrocartilage.
In addition to its fibrinolytic function, PL is a potent cell activator [8].
These data were generated with a different array technology and an activation protocol based on a potent cell mitogen.
The ImmunoGen technology involves attaching a potent cell-killing agent to an antibody that carries it to cancer cells, which are then killed.
They combine computer-based design with specific targeting to elaborate a potent cell-penetrating bioactive peptide derived from cytochrome C.
Buforin IIb-a synthetic analog of buforin II that contains a proline hinge between the two α-helices and a model α-helical sequence at the C-terminus (3× RLLR -is a potent cell-penetRLLR -isntimicrobial potente.
To test whether internalization of CGTs requires dynamin, dynasore, a potent cell-permeable inhibitor of dynamin [22],[23], was preincubated with HeLa cells, prior to addition of toxins.
Interestingly, bright punctate staining for aggresomes localized specifically in the perinuclear or juxta-nuclear sites of the cells individually expressing αA162 and αA168 but not in αAwt and αA172 and these results is very similar with the positive control where cells treated with a potent cell-permeable proteasome inhibitor, MG-132 (5 µM) for 15 hours.
